Your search for

27 results were returned

  1. Legal news
    02 July 2018
    Arrow still flies
    www.twobirds.com/en/news/articles/2018/uk/arrow-still-flies

    During 2016 and 2017 the complex litigation about part of AbbVie's patent portfolio protecting its Humira/adalimumab product drew attention in part because of the granting of a so-called Arrow declaration.

  2. Legal news
    24 June 2020
    UK Supreme Court upholds Kymab's appeal imposing a stricter interpretation of sufficiency of disclosure for patents
    www.twobirds.com/en/news/articles/2020/uk/uk-supreme-court-upholds-kymabs-appeal

    In a judgment handed down today the UK Supreme Court has upheld the appeal of Kymab who had challenged Regeneron's patents covering Kymab's 'Kymouse' transgenic mouse.

  3. Legal news
    22 December 2020
    High Court considers requirements for an exclusive patent licence (Neurim v Mylan)
    www.twobirds.com/en/news/articles/2020/uk/high-court-considers-requirements-for-an-exclusive-patent-licence

    In the LexisNexis case analysis, Senior IP Associate, Will Smith, talks about the decision in the following matter: Neurim Pharmaceuticals (1991) Ltd & Anor v Generics UK Ltd (t\a MYLAN) [2020] EWHC 3270 (Pat). This ...

  4. Legal news
    03 April 2019
    Patents: possible defence to infringement by equivalence
    www.twobirds.com/en/news/articles/2019/global/patents-possible-defence-to-infringement-by-equivalence

    The Intellectual Property Enterprise Court (IPEC) has held that a patent was invalid but also considered a possible defence to infringement by equivalence.

  5. Legal news
    16 November 2017
    Actavis v ICOS– No interim injunction pending Supreme Court appeal
    www.twobirds.com/en/news/articles/2017/global/actavis-v-icos-no-interim-injunction-pending-supreme-court-appeal

    On 10 November 2017, Henry Carr J in the English Patents Court delivered a significant decision which will be of great interest to litigants in the field of generic pharmaceuticals.